Reaction
Calculus Bladder reporting signals
As of the last recalculation, Calculus Bladder appears in 1,346 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is SALMETEROL XINAFOATE (PRR 18.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Salmeterol Xinafoate | 10 | 18.1 | 18.1 |
| Bicalutamide | 13 | 13.3 | 13.3 |
| Teduglutide | 10 | 11.6 | 11.6 |
| Dutasteride | 5 | 9.5 | 9.5 |
| Apalutamide | 5 | 6.6 | 6.6 |
| Leuprolide Acetate | 32 | 6.5 | 6.5 |
| Deferasirox | 10 | 5.9 | 5.9 |
| Interferon Beta-1A | 70 | 5.9 | 5.9 |
| Relugolix | 8 | 5.3 | 5.3 |
| Acalabrutinib | 4 | 5.1 | 5.1 |
| Abiraterone | 4 | 4.6 | 4.6 |
| Enzalutamide | 16 | 4.2 | 4.2 |
| Abiraterone Acetate | 11 | 4.2 | 4.2 |
| Dalfampridine | 18 | 3.9 | 3.9 |
| Diroximel Fumarate | 3 | 3.9 | 3.9 |
| Copper | 10 | 3.6 | 3.6 |
| Droxidopa | 3 | 2.2 | 2.2 |